Neuropace【NPCE】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

12.25

買値

12.30

売値

13.49

出来高

1,914,089

10.30 日の範囲 13.65

5.45 52 週間の範囲 18.15

時価総額

365.639M

前日終値

12.09

始値

10.31

時刻

12.57

最終取引時間

財務取引量

US$ 22,574,492

VWAP

11.7939

平均取引量 (3 か月)

116,617

発行済株式数

29,848,101

配当利回り

PER

-11.13

1 株当たり利益 (EPS)

-1.1

歳入

65.42M

純利益

-32.96M

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically ... NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System. 詳細を表示

セクター

Surgical,med Instr,apparatus

業界

Surgical,med Instr,apparatus

ウェブサイト

www.neuropace.com

本社

Wilmington, Delaware, USA

設立

Neuropace Inc is listed in the Surgical,med Instr,apparatus sector of the ナスダック市場 with ticker NPCE. The last closing price for Neuropace was US$12.09. Over the last year, Neuropace shares have traded in a share price range of US$ 5.45 to US$ 18.15.

Neuropace currently has 29,848,101 shares in issue. The market capitalisation of Neuropace is US$360.86 million. Neuropace has a price to earnings ratio (PE ratio) of -11.13.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.28	-9.46045824095	13.53	13.675	11.62	111374	12.48887724	CS
4	0.22	1.82876142976	12.03	15.11	11.62	191147	13.72109453	CS
12	3.19	35.2097130243	9.06	15.11	8.9079	116617	12.62397443	CS
26	4.95	67.8082191781	7.3	15.11	5.45	93973	10.17612331	CS
52	-3.15	-20.4545454545	15.4	18.15	5.45	95709	10.60219819	CS
156	4.08	49.9388004896	8.17	18.15	1.22	70235	8.10145474	CS
260	-11	-47.311827957	23.25	27.38	1.22	76498	11.33325498	CS

NPCE - Frequently Asked Questions (FAQ)

What is the current Neuropace share price?

The current share price of Neuropace is US$ 12.25

How many Neuropace shares are in issue?

Neuropace has 29,848,101 shares in issue

What is the market cap of Neuropace?

The market capitalisation of Neuropace is USD 360.86M

What is the 1 year trading range for Neuropace share price?

Neuropace has traded in the range of US$ 5.45 to US$ 18.15 during the past year

What is the PE ratio of Neuropace?

The price to earnings ratio of Neuropace is -11.13

What is the cash to sales ratio of Neuropace?

The cash to sales ratio of Neuropace is 5.61

What is the reporting currency for Neuropace?

Neuropace reports financial results in USD

What is the latest annual turnover for Neuropace?

The latest annual turnover of Neuropace is USD 65.42M

What is the latest annual profit for Neuropace?

The latest annual profit of Neuropace is USD -32.96M

What is the registered address of Neuropace?

The registered address for Neuropace is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Neuropace website address?

The website address for Neuropace is www.neuropace.com

Which industry sector does Neuropace operate in?

Neuropace operates in the SURGICAL,MED INSTR,APPARATUS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
JTAIJet AI Inc	US$ 6.02 (133.33%)	104.48M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	254.39M
WRDWeRide Inc	US$ 31.4877 (83.39%)	21.07M
INLFINLIF Limited	US$ 16.27 (80.58%)	7.68M
MBRXMoleculin Biotech Inc	US$ 2.1201 (66.94%)	136.66M
BLACBellevue Life Sciences Acquisition Corporation	US$ 3.08 (-56.31%)	425.19k
BLACUBellevue Life Sciences Acquisition Corporation	US$ 3.36 (-52.68%)	5.21k
CSAICloudastructure Inc	US$ 19.0001 (-49.58%)	1.01M
NEXNNexxen International Ltd	US$ 10.30 (-49.16%)	160.99k
BSLKBolt Projects Holdings Inc	US$ 0.6626 (-46.13%)	13.07M
CNSPCNS Pharmaceuticals Inc	US$ 0.1415 (31.26%)	480.49M
MGOLMGO Global Inc	US$ 0.7176 (-15.08%)	411.17M
SRMSRM Entertainment Inc	US$ 0.6999 (95.50%)	248.48M
INTCIntel Corporation	US$ 23.60 (-2.20%)	225.04M
NVDANVIDIA Corporation	US$ 138.85 (2.63%)	189.56M